RSS   Newsletter   Contact   Advertise with us
Post Online Media

Brigitte Smith steps down from Viveve board

ViveveViveve Medical, a medical technology company,announced that Brigitte Smith has resigned as a director of Viveve's board of directors, effective September 30, 2016.

Ms. Smith also stepped down from her positions as Chairman of the Board and member of the Compensation Committee and Governance and Nominating Committee.

Ms. Smith joined the company in 2007 as a member of the Board of Directors of Viveve, Inc., the company's operating subsidiary, representing GBS Venture Partners Pty Ltd., one of the company's original venture capital investors.

Ms. Smith is co-founder and Managing Director of GBS Venture Partners Pty Ltd., an Australian life science venture capital investor founded in 1998 whose fund, GBS Bioventures III, is one of Viveve's significant stockholders.

Before joining GBS Venture Partners Pty Ltd., Ms. Smith worked with high-tech start-up companies in Australia and the U.S. in fundraising and business development roles. From 1990 to 1992 Ms. Smith also served as a consultant for Bain & Company, a strategic management consulting firm.

Ms. Smith is also on the board of directors of GBS Venture Partners Pty Ltd. portfolio companies in Australia and the United States.

She previously served on the board of directors of KaloBios Pharmaceuticals, Inc., which is listed on the NASDAQ Global Market (KBIO).

Ms. Smith earned her Bachelor of Chemical Engineering with Honors from the University of Melbourne, her Master of Business Administration with Honors from the Harvard Business School and her Masters of International Relations from the Fletcher School of Law and Diplomacy in Boston, Massachusetts, where she was also a Fulbright Scholar.

Ms. Smith is a Fellow of The Australian Institute of Company Directors.


 LATEST MOVES FROM California 


 
 

We use cookies to ensure that we give you the best experience on our website. Please allow cookies for fully-functioning website.

Allow Cookies Privacy Policy